IMS Solutions raises £1.1m led by Midlands Mindforge

London-based IMS Solutions has raised £1.1m in a seed round, led by Midlands Mindforge. It builds biomarker and machine-learning diagnostic tests, including a urine test separating benign from malignant adrenal tumours. SFC Capital, UK Innovation and Science Seed Fund, NG Bio and others also invested. The money will go on regulatory certification and commercial rollout of its adrenal test.